Differential distribution patterns of CRABP I and CRABP II transcripts during mouse embryogenesis.
We have compared the transcript distribution of cellular retinoic acid binding protein (CRABP) I and II genes in mouse embryos at various stages of development. Both CRABP transcripts are present in embryonic structures from the earliest stages studied and exhibit specific patterns of distribution, suggesting that the two retinoic acid (RA) binding proteins perform different functions during mouse embryogenesis. The CRABP I transcript distribution correlates well with structures known to be targets of excess retinoid-induced teratogenesis (e.g. neural crest cells and hindbrain), suggesting that cells expressing CRABP I are those that cannot tolerate high levels of RA for their normal developmental function. The embryonic structures expressing CRABP II transcripts include those structures that have been shown to be adversely affected by excess of retinoids, such as limbs and hindbrain, but CRABP II transcripts are also found in structures not known to be specifically vulnerable to raised RA levels. The CRABP II gene is coexpressed with retinoic acid receptor (RAR)-beta and cellular retinol binding protein (CRBP) I genes in a number of tissues such as the gut endoderm, hypophysis and interdigital mesenchyme, all of which are devoid of CRABP I transcripts. Interestingly, the expression of the three genes, RAR-beta, CRABP II and CRBP I, is induced by retinoic acid, which suggests a link between the synthesis of RA from retinol and the control of expression of subsets of RA-responsive genes. The transcript distribution of CRABP I and II is discussed in relation to the teratogenic effects of RA, and compared to the RA-sensitive pattern of expression of other important developmental genes.
Ruberte
E
E
Laboratoire de Génétique Moléculaire des Eucaryotes, CNRS, U. 184 de Biologie Moléculaire et de Génie Génétique, INSERM, Faculté de Médecine, Strasbourg, France.
Friederich
V
V
Morriss-Kay
G
G
Chambon
P
P
D000014:Abnormalities, Drug-Induced / Q000196:embryology; D000818:Animals; D001345:Autoradiography; D001921:Brain / Q000196:embryology; D002352:Carrier Proteins / Q000235:genetics*; D002490:Central Nervous System / Q000196:embryology; D005314:Embryonic and Fetal Development / Q000235:genetics; D005121:Extremities / Q000196:embryology; D015870:Gene Expression / Q000235:genetics*; D005796:Genes / Q000235:genetics; D050437:Genes, Developmental; D051379:Mice; D015336:Molecular Probe Techniques; D009024:Morphogenesis / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis; D018168:Receptors, Retinoic Acid; D014212:Tretinoin / Q000009:adverse effects / Q000378:metabolism*
D002352:Carrier Proteins; D012333:RNA, Messenger; D018168:Receptors, Retinoic Acid; D014212:Tretinoin